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Abstract 
Background 
Participation in cognitive and physical activities may help to maintain health and wellbeing in 
older people. The Agewell study explored the feasibility of increasing cognitive and physical 
activity in older people through a goal-setting approach. This paper describes the findings of 
the cost-effectiveness analysis.  
 
Methods 
Individuals over the age of 50 and attending an Agewell centre in North Wales were 
randomised to one of three conditions: control (IC), goal-setting (GS), or goal-setting with 
mentoring (GM). We undertook a cost-effectiveness analysis comparing GS vs IC, GM vs IC 
and GM vs GS. The primary outcome measure for this analysis was the QALY, calculated 
using the EQ-5D. Participants’ health and social care contacts were recorded and costed using 
national unit costs.  
 
Results 
Seventy participants were followed-up at 12 months. Intervention set up and delivery costs 
were £252 per participant in the GS arm and £269 per participant in the GM arm. Mean 
health and social care costs over 12 months were £1,240 (s.d. £3,496) per participant in the 
IC arm, £1,259 (s.d. £3,826) per participant in the GS arm and £1,164 (s.d. £2,312) per 
participant in the GM arm. At a willingness to pay threshold of £20,000 per QALY there was 
a 65% probability that GS was cost-effective compared to IC (ICER of £1,070). However, 
there was only a 41% probability that GM was cost-effective compared to IC (ICER of 
£2,830) at a threshold of £20,000 per QALY.  
 
Conclusion 
Setting up and running the community based intervention was feasible. Due to the small 
sample size it is not possible to draw a firm conclusion about cost-effectiveness; however, 
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our preliminary results suggest that goal-setting is likely to be cost-effective compared to the 
control condition of no goal-setting, the addition of mentoring was effective but not cost-
effective. 
 
Trial Registration: ISRCTN30080637 
 
Keywords: cost, ageing, goal-setting, active  
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Introduction 
Life expectancy in the United Kingdom has increased over time and more people are living 
longer [1]. Older people are at risk of social isolation, which is associated with higher rates of 
depression and unmet health care needs [2, 3]. Zaninotto et al [4] determined that quality of 
life was higher in older people who had an absence of depression, absence of limiting 
illnesses, were in the richest quintile of wealth, were in employment, were cohabiting and 
were in the 80
th
 percentile for a positive social network. A review of health promotion 
strategies to prevent social isolation in older people found key determinants to consider when 
addressing social isolation were income and social status, personal health practices and 
coping skills and social support networks [5]. As well as affecting quality of life negatively, 
social isolation in older people is also believed to influence cognitive decline [6]. Alongside 
social engagement, participating in cognitive and physical activities may contribute to 
dementia prevention and risk reduction [7], thus there is a need to identify ways to promote 
and increase cognitive and physical activity in older people within a context of social 
participation. A recent review of interventions aiming to increase physical activity in older 
people concluded that individually tailored interventions with defined personal goals may be 
more effective [8], however the review did not establish the evidence base for the cost-
effectiveness of physical activity interventions. This paper describes the cost of setting up and 
delivering the Agewell community-based goal-setting intervention to increase activity in 
older people, along with cost-effectiveness findings. Effectiveness findings are published in 
Clare et al. [9]. 
 
Methods 
Study design 
Full details of the Agewell study protocol are published as Clare et al. [10]. Agewell was a 
pilot randomised trial aiming to assess the effect of three different types of interview on 
subsequent behaviour change. The three arms of the pilot trial were a control condition (IC), 
a goal-setting condition (GS) and a goal-setting with mentoring condition (GM). Assessments 
were carried out by blinded researchers at baseline and twelve months. Randomisation was 
conducted by the North Wales Organisation for Randomised Trials in Health (NWORTH) 
using a dynamic adaptive computer algorithm. Randomisation was stratified by gender and 
married couples were randomised together to the same study arm to avoid cross-
contamination. The AgeWell study was approved by the School of Psychology Research 
Ethics Committee at Bangor University.  
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Study population 
Individuals aged 50 years and over living in Nefyn, Gwynedd (North Wales) and attending 
the Nefyn Agewell Centre were invited to participate. No exclusion criteria were placed on 
individuals. Individuals attending the centre who did not wish to participate in the study were 
able to attend the centre as usual.  
 
Setting 
The intervention was conducted in partnership with Age Cymru Gwynedd a Môn (ACGM). 
ACGM runs the Agewell Centre in Nefyn, Gwynedd, which was set up as part of the research 
project. The Agewell Centre is based in the village community centre and led by an AGCM 
co-ordinator, supported by a volunteer management group of centre attendees. The Centre is 
open three days a week to provide social contact and a range of meaningful and enjoyable 
activities for over 50s. The program included a range of classes: exercise, computer, history 
and cookery. A range of other activities were also available inducing arts and crafts, bowling, 
Nordic walking, theatre trips, and photography. 
 
Intervention 
Participants randomised to the IC arm received an interview consisting of a general 
discussion about the centre facilities. Participants randomised to the GS arm received a 
structured goal-setting interview. Participants randomised to the GM arm received a 
structured goal-setting interview supplemented by five mentoring telephone calls over the 
course of the one-year follow-up period. 
 
Outcome measures for cost-effectiveness analysis  
A comprehensive list of outcome measures used in the Agewell study is available in the 
published protocol [10]. The primary outcome measure for the cost-effectiveness analysis 
was the quality-adjusted life year (QALY), calculated using the EQ-5D. The EQ-5D is a 
generic, preference based instrument for measuring health-related quality of life [11]. A 
scoring algorithm [12] was used to convert responses into an index value of between -0.59 
and 1, with 1 representing best possible health- related quality of life.  
 
Measurement of intervention costs 
The intervention was conducted at the Agewell centre, with centre set-up costs annuitized 
over 3 years. Staff time developing the intervention was classed as a set-up cost, and 
annuitized over 3 years. Staff time delivering the initial interviews in all three conditions, and 
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conducting on-going mentoring phone calls in the goal-setting with mentoring condition, was 
costed. It was not necessary to discount intervention costs as the follow-up period was one 
year. 
 
Measurement of health and social care costs 
An adapted Client Service Receipt Inventory (CSRI) [13] was used to record participants’ 
contacts with primary and secondary health and social care services. National unit costs for 
the price year 2011-2012 were assigned to services accessed, to calculate a mean total cost 
per participant [14, 15]. Service use costs were not discounted as the follow-up period was 
one year. 
 
Economic evaluation 
We undertook a cost-effectiveness analysis comparing GS vs IC, GM vs IC and GM vs GS. 
A public sector, multi-agency perspective was adopted for the economic evaluation. Cost-
effectiveness analysis was conducted in line with MRC guidelines for the evaluation of 
complex interventions [16], and with our standard operating procedure for economic 
evaluations alongside randomised controlled trials [17]. The base case analysis was an 
intention-to-treat cost-utility analysis using the QALY. Non-parametric bootstrapping with 
1000 replications [18] was used to address the uncertainty associated with point estimates of 
cost effectiveness ratios. To explore whether the results were robust to our assumptions, a 
sensitivity analysis was conducted to test the potential effect of the goal-setting interviews 
and mentoring being delivered by an ACGM staff member on an annual salary of £12,150. 
 
Results 
Seventy-five participants were randomised into the three conditions. At the 12 month follow-
up, 70 participants completed measures for both the clinical-effectiveness and cost-
effectiveness analysis (IC n= 27, GS n = 21, GM n= 22), a retention rate of 93%. 
 
Baseline data 
Normality tests on baseline data indicated that the EQ-5D and cost data were not normally 
distributed, so the non-parametric Kruskal-Wallis test was used to test for significant 
differences between conditions. No significant differences existed at baseline (p=0.193 for 
costs, p=0.905 for EQ-5D; Table 1), so follow-up data used in the economic analysis were 
not adjusted for baseline values.  
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(INSERT TABLE 1 HERE) 
 
 
Mean EQ-5D index scores at baseline were between 0.862 and 0.899. The UK population 
norm for this age group is 0.78 (s.d. 0.26) [19], indicating that Agewell participants had 
comparable health to the general population.  
 
Health and social care use over the study period 
Table 2 shows health and social care contacts occurring between baseline and 12 month 
follow-up for the 70 participants who were assessed at both time-points. The mean cost per 
participant for health and social care contacts was £1,240.23 (s.d. £3,495.88) in the control 
condition, £1,258.66 (s.d. £3,825.71) in the goal-setting condition and £1,163.89 (s.d. 
£2,312.49) in the goal-setting with mentoring condition. The difference in costs between 
conditions was not significant (p=0.806).  
 
(INSERT TABLE 2 HERE) 
 
 
Other activities 
Data on activities undertaken by participants outside of the Agewell centre during the study 
period were collected. This service use was low; 2 participants were enrolled on the local 
authority funded patient referral physical activity scheme and 1 participant was undertaking 
an unspecified local authority funded activity. These activities were not included in the cost 
analysis. 
 
Intervention costs 
Table 3 summarises the cost of setting up and running the Agewell centre and setting up and 
delivering the intervention. The costs of setting up the Agewell centre were annuitized over 3 
years and included an ACGM development officer employed at 50% FTE, equipment costs, 
volunteer training, administration, promotion and recruitment costs. Based on attendance 
figures from the study period we estimated that up to 600 people would attend the centre 
during a 3 year time frame; thus we divided the total cost by 600 to estimate the cost per 
person. Centre running costs included staff costs, rent and administration costs e.g. utility 
bills.  
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Developing the intervention took 65 hours. Training staff to deliver the interviews (both 
control and goal-setting) took 10 hours. In the intervention delivery, the baseline interview 
was conducted by a trained researcher. The average length of interviews for participants in 
the control condition was 60 minutes. The average length of interviews for participants in the 
intervention conditions (GS, GM) was 90 minutes. Participants in the GM condition received 
an average of 5 mentoring phone calls, lasting approximately 10 minutes per call.  
 
 
(INSERT TABLE 3 HERE) 
 
Cost to participants 
Centre attendees were asked for a financial contribution to cover the cost of hiring external 
facilitators, regardless of whether they were trial participants or not. Each attendee paid £2.50 
per session for activities such as tai chi, line dancing, ballroom dancing, calligraphy, choir, 
pottery, exercise class and Nordic walking. The cost of healthy eating and arts classes was 
slightly lower at £2.00 per person. During the study period, trial participants paid a mean of 
£59.55 per person for session fees (s.d. £77.32, range £0 - £272.50). 
 
Cost-effectiveness analysis 
The mean costs (including intervention costs) and QALYs accrued between baseline and 12 
months for each trial arm are shown in Table 4. In this pilot study a small incremental QALY 
gain was seen between GS and IC, and the incremental cost-effectiveness ratio (ICER) 
between conditions was £1,070.  
 
(INSERT TABLE 4 HERE) 
 
 
Figure 1 shows the cost-effectiveness planes for the GS and GM conditions compared to the 
control condition. The majority of plots in the GS cost-effectiveness plane fall in the East of 
the figure, suggesting that GS is more effective than the control condition. More plots fall in 
the West of the cost-effectiveness plane for GM compared to control. 
 
(INSERT FIGURE 1 HERE) 
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Cost-effectiveness acceptability curves indicate the probability that an intervention is cost-
effective at a range of willingness to pay thresholds. The cost-effectiveness acceptability 
curve in Figure 2 indicates a 65% probability that GS was cost-effective compared to the 
control condition at the NICE threshold of £20,000 per QALY [20]. However, the cost-
effectiveness acceptability curve for GM compared to control indicated only a 41% 
probability of being cost-effective compared to the control condition at a threshold of 
£20,000 per QALY. Comparing GM to GS, there was a 36% probability that GM was cost-
effective at a threshold of £20,000 per QALY. 
(INSERT FIGURE 2 HERE) 
 
Sensitivity analysis 
In the base case analysis, the goal-setting interviews and mentoring calls were conducted by a 
researcher on an annual salary of approximately £33,000. We conducted a sensitivity analysis 
to explore the effect of the goal-setting interviews and mentoring being delivered by an 
ACGM staff member on an annual salary of approximately £12,000. In this scenario the cost 
per participant (including centre costs and intervention costs) was £228.94 in the control 
condition, £233.18 in the goal-setting condition and £240.25 in the goal-setting with 
mentoring condition (Table 5). 
 
(INSERT TABLE 5 HERE) 
 
 
Discussion 
The Agewell pilot study explored the feasibility of setting up and delivering a community 
based goal-setting intervention with the aim of promoting physical and cognitive activity in 
older people. The Agewell centre was set up and the target study size of 75 participants to be 
randomised was achieved, indicating that the study was feasible. Attendance at the centre was 
good, with participants attending a mean of 34 activity sessions over the year. Furthermore, at 
12 month follow-up 70 participants were assessed, which is a retention rate of 93%. The 
sample size for cost-effectiveness analysis is often smaller than the full clinical effectiveness 
sample due to fewer participants providing complete information on health and social care 
resource use. In this study, all 70 participants in the clinical effectiveness sample completed 
the resource use questionnaire and were used in the cost-effectiveness analysis. Health and 
social care costs did not differ significantly between the control and goal-setting conditions 
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over 12 months, and the incremental cost between conditions was low meaning that the 
intervention is unlikely to have affected participants’ patterns of health and social care use in 
the short-term. 
 
The partnership with Age Cymru Gwynedd a Môn (ACGM) and the involvement of the 
volunteer management group of centre attendees was key to the success of the study. The 
program of activities offered at the Agewell Centre was developed following consultation 
with centre attendees, encouraging engagement between participants and the centre. A co-
ordinator was employed by the centre, and trained volunteers provided additional support. 
Attendance records for the centre indicate that up to 200 people could attend the centre 
annually. The annual cost of running the centre was estimated to be £38,122 in total or £191 
per attendee (including non-trial attendees). In comparison to centre set-up and running costs, 
the delivery of the intervention was low cost as it only required the additional staff time 
involved in conducting the initial goal-setting interviews and subsequent mentoring calls.  
 
The findings from the clinical effectiveness analysis in Clare et al. [9] showed that 
participants in all three arms of the pilot study benefitted across a range of outcome 
measures; however a specific focus on identifying individual behaviour change goals in a 
goal-setting interview was required to achieve increased activity engagement and greater 
benefits in cognition, health, diet and fitness. This paper explored the cost-effectiveness of 
the intervention and found that goal-setting is likely to be cost-effective compared to the 
control condition; however, while the addition of mentoring is likely to be effective, it is 
unlikely to be cost-effective. The goal-setting interviews were carried out by a researcher; 
however a sensitivity analysis was undertaken exploring the effect of the interviews being 
carried out by an ACGM staff member on a lower salary. The sensitivity analysis supported 
the base case analysis, in that goal-setting was likely to be cost-effective compared to the 
control condition. 
 
 
Conclusion 
The preliminary cost-effectiveness results indicate a high probability that the goal-setting 
intervention is cost-effective compared to the control condition at a threshold of £20,000-
£30,000 per QALY gained. However, due to the small sample size and the QALY differences 
between groups not being statistically significant, it is not possible to conclusively state that 
the intervention was cost-effective compared to control, and a larger scale study is required. 
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Community-based interventions aimed at increasing physical, cognitive and social activity in 
older people may have a beneficial effect on health, so low-cost interventions such as the 
Agewell pilot study have an important role to play in keeping people active in the 
community. 
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Table 1: Baseline characteristics for the full sample 
 IC (n=27) 
Mean (s.d.) 
GS (n=24) 
Mean (s.d.) 
GM (n=24) 
Mean (s.d.) Gender: Female (n, %) 23 (85.2%  23 (95.8%  19 (79.2%  
Age 70.22 (7.77) 67.50 (7.66) 66.67 (8.19) 
Years of education 12.70 (2.91) 13.79 (3.18) 13.58 (2.68) 
Living situation: living with others 15 (55.6%) 16 (66.7%) 18 (75.0%) 
Social capital: good 8 (29.6%) 9 (37.5%) 8 (33.3%) 
Social capital: poor 19 (70.4%) 15 (62.5%) 16 (66.7%) 
Material deprivation: none 10 (37.0%) 7 (29.2%) 2 (8.3%) 
Material deprivation: moderate 12 (44.4%) 13 (54.2%) 15 (62.5%) 
Material deprivation: high 5 (18.5%) 4 (16.7%) 7 (29.2%) 
EQ-5D index value 0.899 (0.141) 0.891 (0.133) 0.862 (0.227) 
Subjective health: poor/ very poor 0 0 2 (8.3%) 
Subjective health: not too good 4 (14.8%) 3 (12.5%) 0 
Subjective health: good/ very good 23 (85.2%) 21 (87.5%) 22 (91.7%) 
Health and social care contact cost for 
the 3 months before baseline 
£255.84 (£374.78) £169.96 (£250.47) £370.96 (£1,406.69) 
 
Note: IC= control, GS: goal-setting, GM: goal-setting with mentoring 
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Table 2: Health and social care contacts in the 12 months following baseline 
 Control (n=27) Goal-setting (n=21) Goal-setting with mentoring (n=22) 
 N (%) 
Total 
contacts 
Total cost 
Mean cost per 
participant (SD) 
N (%) 
Total 
contacts 
Total cost 
Mean cost per 
participant (SD) 
N (%) 
Total 
contacts 
Total cost 
Mean cost per 
participant (SD) 
General practitioner 24 (88.9%) 108 £7,388 £273.63 (£355.30) 17 (81.0%) 63 £4,073 £193.95 (£132.61) 19 (86.4%) 48 £3,024 £137.45 (£107.61) 
Practice nurse 25 (92.6%) 58 £812 £30.07 (£28.72) 19 (90.5%) 77 £1,078 £51.33 (£75.57) 15 (68.2%) 43 £602 £27.36 (£40.64) 
District nurse 2 (7.4%) 4 £244 £9.04 (£35.61) 1 (4.8%) 4 £280 £13.33 (£61.10) 3 (13.6%) 9 £618 £28.09 (£104.88) 
Counsellor 0 0 0 0 1 (4.8%) 1 £60 £2.86 (£13.09) 0 0 0 0 
Physiotherapist 6 (22.2%) 47 £1,551 £57.44 (£150.28) 4 (19.0%) 24 £792 £37.71 (£84.32) 5 (22.7%) 60 £1,980 £90.00 (£243.18) 
Occupational health 
therapist 
0 0 0 0 0 0 0 0 1 (4.5%) 1 £33 £1.50 (£7.04) 
Chiropodist 7 (25.9%) 21 £630 £23.33 (£43.50) 4 (19.0%) 19 £570 £27.14 (£81.56) 2 (9.1%) 12 £360 £16.36 (£59.80) 
Dietician 2 (7.4%) 8 £272 £10.07 (£46.02) 1 (4.8%) 8 £272 £12.95 (£59.36) 0 0 0 0 
Dentist 1 (3.7%) 2 £50 £1.85 (£9.62) 3 (14.3%) 5 £125 £5.95 (£15.62) 1 (4.5%) 1 £25 £1.14 (£5.33) 
Optician 1 (3.7%) 1 £21 £0.78 (£4.04) 0 0 0 0 3 (13.6%) 3 £63 £2.86 (£7.38) 
Alternative therapist 2 (7.4%) 3 £51 £1.89 (£7.20) 0 0 0 0 1 (4.5%) 8 £136 £6.18 (£29.00) 
Gynaecology nurse 0 0 0 0 1 (4.8%) 3 £243 £11.57 (£53.03) 0 0 0 0 
Total community 
service use 
- 252 £11,019 £408.11 (£417.60) - 204 £7,493 £356.81 (£357.75) - 185 £6,841 £310.95 (£372.37) 
Outpatient service 14 (51.9%) 48 £5,088 £188.44 (£279.42) 10 (47.6%) 20 £2,120 £100.95 (£131.87) 12 (54.5%) 17 £1,802 £81.91 (£103.09) 
Inpatient nights 3 (11.1%) 28 £17,379 £643.67 (£3,032.70) 1 (4.8%) 21 £16,728 £796.56 (£3,650.30) 4 (18.2%) 14 £16,872 £766.89 (£2,024.62) 
Accident and 
Emergency 
0 0 0 0 1 (4.8%) 1 £91 £4.33 (£19.86) 1 (4.5%) 1 £91 £4.14 (£19.40) 
Total hospital use - - £22,467 £832.12 
(£3,159.32) 
- - £18,939 £901.85 
(£3,725.00) 
- - £18,765 £852.94 
(£2,093.18) 
TOTAL - - £33,486 £1,240.23 
(£3,495.88) 
- - £26,432 £1,258.66 
(£3,825.71) 
- - £25,606 £1,163.89 
(£2,312.49) 
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Table 3: Costs of setting up and running the centre and intervention 
 Total cost, annuitized 
over 3 years 
Cost per 
person 
One-off centre set-up cost £11,600.14 £19.33
1
 
Annual cost of running the centre  £38,122.44 £190.61
2
 
Intervention development and set-up cost £862.62 £11.50
3
 
60 minute control interview cost per person- IC arm - £20.32 
90 minute goal-setting interview cost per person- GS arm - £30.48 
90 minute goal-setting interview and mentoring cost per person- GM arm - £47.41 
Total cost per participant, including centre and intervention costs 
IC arm £241.77 
GS arm £251.93 
GM arm £268.86 
IC= control, GS: goal-setting, GM: goal-setting with mentoring 
1
Based on up to 600 people attending over 3 years 
2
Based on up to 200 people attending per year 
3
Based on the 75 participants randomised in the study 
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Table 4: Incremental costs and QALYs between conditions at 12 months 
 IC (n=27) GS (n=21) GM (n=22) 
Mean (s.d.) cost £1,482.00 (£3,495.88) £1,510.59 (£3,825.71) £1,432.75 (£2,312.49) 
Mean (s.d.) QALY 0.8464 (0.1849) 0.8731 (0.1670) 0.8290 (0.2442) 
 GS v IC  
(95% CI) 
GM v IC  
(95% CI) 
GM v GS  
(95% CI)  
Incremental cost 
£28.58 
(-£2,045.86 to £1,957.86) 
-£49.25 
(-£1,728.65 to £1,528.18) 
-£77.83 
(-£2,150.62 to £1,540.99 ) 
Incremental QALY 
0.0267 
(-0.078 to 0.127) 
-0.0174 
(-0.156 to 0.092) 
-0.0441 
(-0.163 to 0.077) 
ICER £1,070 £2,830 £1,765 
Probability of cost-
effectiveness at £20,000 per 
QALY 
65% 41% 36% 
Probability of cost-
effectiveness at £30,000 per 
QALY 
68% 44% 33% 
Note: GS: goal-setting, GM: goal-setting with mentoring, IC= control 
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Table 5: Sensitivity analysis 
 GS v IC  
(95% CI) 
GM v IC  
(95% CI) 
GM v GS  
(95% CI)  
Incremental cost 
£22.66 
(-£2,072.96 to £2,365.28) 
-£65.03 
(-£1,792.80 to £1,404.68) 
-£87.69 
(-£2,275.11 to £1,492.09 ) 
Incremental QALY 
0.0267 
(-0.078 to 0.127) 
-0.0174 
(-0.156 to 0.092) 
-0.0441 
(-0.163 to 0.077) 
ICER £849 £3,737 £1,988 
Probability of cost-
effectiveness at £20,000 
per QALY 
65% 44% 32% 
Probability of cost-
effectiveness at £20,000 
per QALY 
67% 43% 28% 
Note: GS: goal-setting, GM: goal-setting with mentoring, IC= control 
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Figure 1: Cost-effectiveness plane for the QALY with 1,000 bootstrapped ICER estimates; GS v IC 
on the left and GM v IC on the right 
 
  
  19 
Figure 2: Cost-effectiveness acceptability curves for GS vs IC and GM vs IC 
 
 
 
